LLY · News · 20260824N
2026 Financial Guidance Update
ELI LILLY & Co · 2026-08-24 · Importance 75 · Surprise 60 · In source text
Eli Lilly’s management guided fiscal 2026 revenue to between $85 billion and $87 billion. The guidance indicates expected revenue well above the company’s $22.974 billion materiality benchmark. The outlook is tied to continued growth in Lilly’s diabetes and obesity portfolio, including Mounjaro and Zepbound.
Key facts
- Management has guided Eli Lilly's fiscal 2026 revenue between $85 billion and $87 billion. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| revenue | positive | committed | — | Management has guided Eli Lilly's fiscal 2026 revenue between $85 billion and $87 billion. |